Your session is about to expire
← Back to Search
Skin-to-Skin Contact for Premature Birth
N/A
Waitlist Available
Research Sponsored by Norwegian University of Science and Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Preterm infants at 28-32 weeks of gestation (born 12-8 weeks before term)
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 year
Awards & highlights
Study Summary
This trial is studying the effects of skin-to-skin contact on preterm infants.
Who is the study for?
This trial is for preterm infants born between 28-32 weeks of gestation. It's not suitable for those needing immediate medical interventions after birth.Check my eligibility
What is being tested?
The study compares the effects of skin-to-skin contact with standard care in an incubator on preterm infants' physiological and emotional responses, as well as their general movements.See study design
What are the potential side effects?
Since this trial involves non-invasive methods like skin-to-skin contact, there are minimal expected side effects compared to medical or drug interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My baby was born between 28 and 32 weeks of pregnancy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
cognitive scorer at two years corrected age
Secondary outcome measures
Child Behaviour
Developmental skills at two years corrected age
Anxiety
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: skin-to-skinExperimental Treatment1 Intervention
immediately after birth the baby is laid on mother's chest for as long as justifiable medically to max 2 hours.
Group II: standard careActive Control1 Intervention
after birth the baby is transferred to the neonatal intensive care unit
Find a Location
Who is running the clinical trial?
Norwegian University of Science and TechnologyLead Sponsor
648 Previous Clinical Trials
2,164,845 Total Patients Enrolled
7 Trials studying Premature Birth
861 Patients Enrolled for Premature Birth
Drammen sykehusOTHER
10 Previous Clinical Trials
99,889 Total Patients Enrolled
IWK Health CentreOTHER
125 Previous Clinical Trials
100,365 Total Patients Enrolled
3 Trials studying Premature Birth
918 Patients Enrolled for Premature Birth
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My baby was born between 28 and 32 weeks of pregnancy.My infant requires immediate medical care.
Research Study Groups:
This trial has the following groups:- Group 1: skin-to-skin
- Group 2: standard care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger